These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 7200956

  • 1. Immune response of neonates to pneumococcal polysaccharide-protein conjugate.
    Lin KT, Lee CJ.
    Immunology; 1982 Jun; 46(2):333-42. PubMed ID: 7200956
    [Abstract] [Full Text] [Related]

  • 2. Maternal immunity and antibody response of neonatal mice to pneumococcal type 19F polysaccharide.
    Lee CJ, Ching ED, Vickers JH.
    J Clin Microbiol; 1991 Sep; 29(9):1904-9. PubMed ID: 1774315
    [Abstract] [Full Text] [Related]

  • 3. Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate.
    Lu CH, Lee CJ, Kind P.
    Infect Immun; 1994 Jul; 62(7):2754-60. PubMed ID: 8005665
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.
    Chu RS, McCool T, Greenspan NS, Schreiber JR, Harding CV.
    Infect Immun; 2000 Mar; 68(3):1450-6. PubMed ID: 10678959
    [Abstract] [Full Text] [Related]

  • 11. Protection of infant mice from challenge with Streptococcus pneumoniae type 19F by immunization with a type 19F polysaccharide--pneumolysoid conjugate.
    Lee CJ, Lock RA, Andrew PW, Mitchell TJ, Hansman D, Paton JC.
    Vaccine; 1994 Aug; 12(10):875-8. PubMed ID: 7975828
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bacterial capsular polysaccharides--biochemistry, immunity and vaccine.
    Lee CJ.
    Mol Immunol; 1987 Oct; 24(10):1005-19. PubMed ID: 3119993
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA, Rijkers GT, Voorhorst-Ogink MM, Zegers BJ, Sanders LA.
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [Abstract] [Full Text] [Related]

  • 16. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
    Moens L, Jeurissen A, Mittler RS, Wuyts G, Michiels G, Boon L, Ceuppens JL, Bossuyt X.
    J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
    [Abstract] [Full Text] [Related]

  • 17. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines.
    Shapiro DA, Threadgill DS, Copfer MJ, Corey DA, McCool TL, McCormick LL, Magnuson TR, Greenspan NS, Schreiber JR.
    J Immunol; 1998 Oct 01; 161(7):3393-9. PubMed ID: 9759856
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pneumococcal infection and immunization in children.
    Lee CJ, Wang TR.
    Crit Rev Microbiol; 1994 Oct 01; 20(1):1-12. PubMed ID: 8185832
    [Abstract] [Full Text] [Related]

  • 20. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.
    Microb Pathog; 2009 Sep 01; 47(3):151-6. PubMed ID: 19467319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.